Recent Updates
Recently added Catalysts
CUVL Neutral Sentiment

CLINUVEL Annual Results — Investor Webinar

Key Takeaway: CLINUVEL held an investor webinar to discuss its annual results. The event covered various aspects of the company, including its pharmaceutical development, photomedicine foundation, and financial summary. Investors were provided with insights into the company's performance and future directions.
Price reaction · baseline $7.15 (2026-08-19 close) · hit after-hours · clean, no other CUVL news in the window
day 0 close · peak
+9.1%
day 1
+3.8%
day 3
+6.9%

Market Sentiment Analysis

Full Press Release Details

• About About CLINUVEL People Corporate Governance Photomedicine Foundation Annual Reports
• Pharmaceuticals Pharmaceutical Development The Science Disease Entities Products
• PhotoCosmetics About PhotoCosmetics Polychromatic Photoprotection DNA Repair Melanogenesis
• Investors Investors Information ASX Announcements SEC Filings Analyst Coverage Media Coverage Company Snapshot Financial Summary Shareholder Information Investor Enquiry
• News
• Contact
• Store
• About CLINUVEL
• People
• Corporate Governance
• Photomedicine Foundation
• Annual Reports
• Pharmaceutical Development
• The Science
• Disease Entities
• Products
• About PhotoCosmetics
• Polychromatic Photoprotection
• DNA Repair
• Melanogenesis
• Investors Information
• ASX Announcements
• SEC Filings
• Analyst Coverage
• Media Coverage
• Company Snapshot
• Financial Summary
• Shareholder Information
• Investor Enquiry
Last updated: Aug 19, 2026